Literature DB >> 32533339

The circRNA-miRNA-mRNA regulatory network in systemic lupus erythematosus.

Junhui Zhang1,2, Yuan Liu3, Guixiu Shi4.   

Abstract

INTRODUCTION/
OBJECTIVES: Systemic lupus erythematosus (SLE) was an autoimmune disease with a large variety of clinical manifestations and involving many organs. Its exact etiology was unclear, and studies had shown that T cells may play an important role. In this study, we wished to study the regulatory mechanism of circRNA in the T cells from SLE patients.
METHOD: GSE84655 was retrieved from the GEO database, and the corresponding probe name was converted into an international standard circRNA name by using the practical extraction and report language. The differentially expressed circRNAs (DECs) were analyzed by using R software. Subsequently, we used multiple bioinformatics methods to obtain the target miRNAs of circRNAs and the downstream mRNAs of miRNAs. Finally, a circRNA-miRNA-mRNA regulatory network was constructed and visualized by using Cytoscape 3.6.1 software.
RESULTS: There were a total of 29 DECs that had been identified, including 2 upregulated circRNAs and 27 downregulated circRNAs. After a lot of in-depth analysis, we finally obtained a circRNA-miRNA-mRNA regulatory network consisting of 8 DECs (hsa_circ_0006770, hsa_circ_0002904, hsa_circ_0034044, hsa_circ_0023685, hsa_circ_0049271, hsa_circ_0074491, hsa_circ_0074559, and hsa_circ_0023461), 4 overlap miRNAs (hsa-miR-326, hsa-miR-569, hsa-miR-638, and hsa-miR-1246), and 13 target mRNAs (EPHB3, USH1G,UBE4A, DCAF7, TBL1XR1, SLC27A4, SMO, NAA30, RSBN1, PLAG1, SOX2, GPATCH11, and DYRK1A).
CONCLUSIONS: This study could provide a novel insight into the role of circRNA and the circRNA-miRNA-mRNA regulation network in the SLE. However, it also needed to be verified by subsequent experiments and clinical studies. Key Points • There were 29 DECs (2 up and 27 down) between T cells of SLE and health control. • Hsa-miR-338-3p, hsa-miR-767-3p, and hsa-miR-1827 were the most frequent miRNAs. • We obtained a circRNA-miRNA-mRNA regulatory network for SLE.

Entities:  

Keywords:  Circular RNA; Systemic lupus erythematosus; mRNA; miRNA

Mesh:

Substances:

Year:  2020        PMID: 32533339     DOI: 10.1007/s10067-020-05212-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  33 in total

1.  Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures.

Authors:  H L Sanger; G Klotz; D Riesner; H J Gross; A K Kleinschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

2.  Microarray expression profile of circular RNAs and mRNAs in children with systemic lupus erythematosus.

Authors:  Shipeng Li; Junmei Zhang; Xiaohua Tan; Jianghong Deng; Yan Li; Yurong Piao; Chao Li; Wenxu Yang; Wenxiu Mo; Jiapeng Sun; Fei Sun; Tongxin Han; Jiang Wang; Weiying Kuang; Caifeng Li
Journal:  Clin Rheumatol       Date:  2019-01-09       Impact factor: 2.980

3.  Circular RNA expression profile and potential function of hsa_circ_0045272 in systemic lupus erythematosus.

Authors:  Lian-Ju Li; Zhi-Wei Zhu; Wei Zhao; Sha-Sha Tao; Bao-Zhu Li; Shu-Zhen Xu; Jie-Bing Wang; Ming-Yue Zhang; Jun Wu; Rui-Xue Leng; Yin-Guang Fan; Hai-Feng Pan; Dong-Qing Ye
Journal:  Immunology       Date:  2018-05-23       Impact factor: 7.397

4.  Identification of circular RNA Hsa_circ_0001879 and Hsa_circ_0004104 as novel biomarkers for coronary artery disease.

Authors:  Laiyuan Wang; Chong Shen; Yanyu Wang; Tianyu Zou; Huijuan Zhu; Xiaomei Lu; Lin Li; Bin Yang; Jichun Chen; Shufeng Chen; Xiangfeng Lu; Dongfeng Gu
Journal:  Atherosclerosis       Date:  2019-05-09       Impact factor: 5.162

Review 5.  Sex Differences in Systemic Lupus Erythematosus: Epidemiology, Clinical Considerations, and Disease Pathogenesis.

Authors:  Julie S Nusbaum; Ibraheem Mirza; Justine Shum; Robert W Freilich; Rebecca E Cohen; Michael H Pillinger; Peter M Izmirly; Jill P Buyon
Journal:  Mayo Clin Proc       Date:  2020-02       Impact factor: 7.616

6.  Comprehensive circular RNA profiles in plasma reveals that circular RNAs can be used as novel biomarkers for systemic lupus erythematosus.

Authors:  Haixia Li; Kaifei Li; Weinan Lai; Xin Li; Hongxia Wang; Jia Yang; Shuai Chu; Haifang Wang; Chunmin Kang; Yurong Qiu
Journal:  Clin Chim Acta       Date:  2018-02-20       Impact factor: 3.786

Review 7.  Regulatory Role of Circular RNAs and Neurological Disorders.

Authors:  Gabriele Floris; Longbin Zhang; Paolo Follesa; Tao Sun
Journal:  Mol Neurobiol       Date:  2016-08-24       Impact factor: 5.590

8.  RNA-seq of circular RNAs identified circPTPN22 as a potential new activity indicator in systemic lupus erythematosus.

Authors:  Q Miao; Z Zhong; Z Jiang; Y Lin; B Ni; W Yang; J Tang
Journal:  Lupus       Date:  2019-03-14       Impact factor: 2.911

Review 9.  One year in review 2019: systemic lupus erythematosus.

Authors:  Dina Zucchi; Elena Elefante; Emanuele Calabresi; Viola Signorini; Alessandra Bortoluzzi; Chiara Tani
Journal:  Clin Exp Rheumatol       Date:  2019-07-19       Impact factor: 4.473

Review 10.  T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy.

Authors:  Amir Sharabi; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2020-01-16       Impact factor: 20.543

View more
  12 in total

Review 1.  Past, Present and Future: The Relationship Between Circular RNA and Immunity.

Authors:  Junjie Gu; Chongying Su; Fei Huang; Yuwei Zhao; Jing Li
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

Review 2.  Current Understanding of Circular RNAs in Systemic Lupus Erythematosus.

Authors:  Hongjiang Liu; Yundong Zou; Chen Chen; Yundi Tang; Jianping Guo
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

3.  Comparative analysis of circRNA expression profile and circRNA-miRNA-mRNA regulatory network between palmitic and stearic acid-induced lipotoxicity to pancreatic β cells.

Authors:  Yunjin Zhang; Qingrui Zhao; Shenghan Su; Lingfeng Dan; Xuebei Li; Yu Wang; Yuqing Lin; Zhen Tian; Changhao Sun; Huimin Lu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  Targeting of EIF4EBP1 by miR-99a-3p affects the functions of B lymphocytes via autophagy and aggravates SLE disease progression.

Authors:  Meng Yang; Binbin Yang; Danqi Deng
Journal:  J Cell Mol Med       Date:  2021-10-20       Impact factor: 5.310

5.  Circular RNA circCHFR downregulation protects against oxidized low-density lipoprotein-induced endothelial injury via regulation of microRNA-15b-5p/growth arrest and DNA damage inducible gamma.

Authors:  Yang Li; Bing Wang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

6.  Identification and Contribution of Inflammation-Induced Novel MicroRNA in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Ram P Singh; Bevra H Hahn; David S Bischoff
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

7.  Circular RNA: A novel type of biomarker for glioma (Review).

Authors:  Wei Sun; Huandi Zhou; Xuetao Han; Liubing Hou; Xiaoying Xue
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

8.  CircMAPK9 promotes the progression of fibroblast-like synoviocytes in rheumatoid arthritis via the miR-140-3p/PPM1A axis.

Authors:  Zhihuan Luo; Shaojian Chen; Xiaguang Chen
Journal:  J Orthop Surg Res       Date:  2021-06-21       Impact factor: 2.359

Review 9.  Immunomodulatory Effect of MSCs and MSCs-Derived Extracellular Vesicles in Systemic Lupus Erythematosus.

Authors:  Chunjuan Yang; Jianmei Sun; Yipeng Tian; Haibo Li; Lili Zhang; Jinghan Yang; Jinghua Wang; Jiaojiao Zhang; Shushan Yan; Donghua Xu
Journal:  Front Immunol       Date:  2021-09-16       Impact factor: 7.561

10.  Silencing circular RNAPTPN12 promoted the growth of keloid fibroblasts by activating Wnt signaling pathway via targeting microRNA-21-5p.

Authors:  Fei Liu; Tao Li; Xiaoan Zhan
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.